Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
Germany's Bundestag extends two armed forces missions abroad - 2New science points to 4 distinct types of autism
- 3Top 15 Style Creators Changing the Business
- 4Tear gas and arrests: Iranian regime continues crackdown on protesters amid economic unrest
- 5Eleven arrested over mass shooting in South Africa tavern
- US students studying housing, health outcomes and sustainability win 2026 Rhodes scholarships
- Astrophotographer captures rare footage of the Hubble Telescope crossing the sun (video)
- The Effect of Online Organizations on Society: Beating the Difficulties
- Great DSLR Cameras for Photography Devotees
- The 10 Most Significant Virtual Entertainment Missions
- Peloton recalls more than 800,000 bikes after broken seat posts injure users
- Ageless Tastefulness: An Outline of Valuable Gemstones and Adornments
- Experience Unrivaled Sound: Top Speakers You Really want to Hear
- RFK Jr. says fewer flu shots for kids may be 'better.' What experts say.
